Quantinno Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.79M | Sell |
35,686
-60,865
| -63% | -$6.46M | 0.02% | 907 |
|
|
2025
Q1 | $12M | Sell |
96,551
-5,017
| -5% | -$623K | 0.08% | 303 |
|
|
2024
Q4 | $12.5M | Buy |
101,568
+42,655
| +72% | +$5.25M | 0.12% | 149 |
|
|
2024
Q3 | $6.56M | Buy |
58,913
+42,924
| +268% | +$4.78M | 0.09% | 261 |
|
|
2024
Q2 | $1.71M | Buy |
15,989
+2,096
| +15% | +$224K | 0.03% | 628 |
|
|
2024
Q1 | $1.67M | Buy |
13,893
+10,473
| +306% | +$1.26M | 0.04% | 578 |
|
|
2023
Q4 | $421K | Sell |
3,420
-6,227
| -65% | -$767K | 0.01% | 866 |
|
|
2023
Q3 | $1.25M | Buy |
9,647
+3,156
| +49% | +$409K | 0.06% | 457 |
|
|
2023
Q2 | $805K | Sell |
6,491
-7,622
| -54% | -$945K | 0.05% | 479 |
|
|
2023
Q1 | $2.07M | Sell |
14,113
-7,538
| -35% | -$1.1M | 0.14% | 181 |
|
|
2022
Q4 | $3.45M | Buy |
21,651
+15,711
| +264% | +$2.5M | 0.26% | 67 |
|
|
2022
Q3 | $792K | Buy |
5,940
+12
| +0.2% | +$1.6K | 0.1% | 257 |
|
|
2022
Q2 | $925K | Sell |
5,928
-228
| -4% | -$35.6K | 0.13% | 197 |
|
|
2022
Q1 | $958K | Sell |
6,156
-116
| -2% | -$18.1K | 0.15% | 173 |
|
|
2021
Q4 | $799K | Buy |
+6,272
| New | +$799K | 0.14% | 173 |
|
|
2020
Q1 | – | Sell |
-2,591
| Closed | -$387K | – | 453 |
|
|
2019
Q4 | $387K | Buy |
+2,591
| New | +$387K | 0.24% | 177 |
|
|
2019
Q3 | – | Sell |
-3,258
| Closed | -$464K | – | 453 |
|
|
2019
Q2 | $464K | Sell |
3,258
-987
| -23% | -$141K | 0.27% | 144 |
|
|
2019
Q1 | $607K | Buy |
4,245
+2,041
| +93% | +$292K | 0.39% | 66 |
|
|
2018
Q4 | $273K | Buy |
+2,204
| New | +$273K | 0.22% | 233 |
|